March 10, 2009; 72 (10) Articles
Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood
Yann Mikaeloff, Guillaume Caridade, Samy Suissa, Marc Tardieu
First published October 8, 2008, DOI: https://doi.org/10.1212/01.wnl.0000335762.42177.07
Yann Mikaeloff
Guillaume Caridade
Samy Suissa
Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood
Yann Mikaeloff, Guillaume Caridade, Samy Suissa, Marc Tardieu
Neurology Mar 2009, 72 (10) 873-880; DOI: 10.1212/01.wnl.0000335762.42177.07
Citation Manager Formats
Make Comment
See Comments

Article Information
vol. 72 no. 10 873-880
PubMed:
Print ISSN:
Online ISSN:
History:
- First Published October 8, 2008.
Article Versions
- Previous version (October 8, 2008 - 12:50).
- You are viewing the most recent version of this article.
Copyright & Usage:
© 2009
Author Disclosures
- Yann Mikaeloff, MD, PhD,
- Guillaume Caridade, MSc,
- Samy Suissa, PhD and
- Marc Tardieu, MD, PhD
- Yann Mikaeloff, MD, PhD,
- Guillaume Caridade, MSc,
- Samy Suissa, PhD and
- Marc Tardieu, MD, PhD
- From Assistance Publique-Hôpitaux de Paris, Service de Neurologie Pédiatrique and Centre de Référence National des Maladies Inflammatoires du Cerveau de l’Enfant (Y.M., G.C., M.T.), INSERM U822 (Y.M., G.C.), and INSERM U802 (M.T.), Hôpital Bicêtre, Université Paris Sud 11, Le Kremlin Bicêtre, France; and Division of Clinical Epidemiology (S.S.), McGill University and Royal Victoria Hospital, Montreal, Canada.
- Address correspondence and reprint requests to Dr. Yann Mikaeloff, Service de Neurologie Pédiatrique, CHU Bicêtre, Assistance Publique-Hôpitaux de Paris, 78 Avenue du Général Leclerc, 94275 Le Kremlin-Bicêtre Cedex, France yann.mikaeloff{at}bct.aphp.fr
Article usage
Cited By...
Letters: Rapid online correspondence
- Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood
- Michel Lievre, Lyon 1 University, Service de Pharmacologie Clinique, Faculté de Médecine, rue Guillaume Paradin, 69008 Lyon, Franceml@upcl.univ-lyon1.fr
- Members of the Epidemiology working group of the French pharmacovigilance commission: Dominique Costagliola, Stephen Evans, Annie Fourrier, Jean-Louis Imbs, Daniel Levy-Bruhl, Louis Merle, Joelle Micallef, Emmanuel Oger
Submitted March 10, 2009 - Editor's Note
- Richard J. Kryscio, PhD, Associate Editor, Biostatistics, Neurologykpieper@neurology.org
Submitted March 10, 2009 - Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood
- Alain Braillon, Department of Public Health, Hôpital Nord, 80054 Amiens CEDEX 1, Francebraillon.alain@chu-amiens.fr
- Gérard Dubois
Submitted December 05, 2008
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement
Dr. Nicole Sur and Dr. Mausaminben Hathidara
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Articles
Recombinant hepatitis B vaccine and the risk of multiple sclerosisA prospective studyMiguel A. Hernán, Susan S. Jick, Michael J. Olek et al.Neurology, September 13, 2004 -
Editorials
Hepatitis vaccines and pediatric multiple sclerosisDoes timing or type matter?Jayne M. Ness, James F. Bale, Jr et al.Neurology, December 17, 2008 -
Special Article
Practice guideline update summary: Vaccine-preventable infections and immunization in multiple sclerosisReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of NeurologyMauricio F. Farez, Jorge Correale, Melissa J. Armstrong et al.Neurology, August 28, 2019 -
Correspondence
HEPATITIS B VACCINE AND THE RISK OF CNS INFLAMMATORY DEMYELINATION IN CHILDHOODM. Lièvre, Members of the Epidemiology Working Group of the French Pharmacovigilance Commission, D. Costagliola et al.Neurology, October 26, 2009